Irofulven is Active against Metastatic Hormone-Refractory Prostate ...
... Irofulven is Active against Metastatic Hormone-Refractory Prostate Cancer A phase II study has shown that the new compound Irofulven (hydroxymethylacylfulvene) produces responses in men with hormone ...
- professional.cancerconsultants.com/oncology_main_news.aspx?id=33276
Prostate Cancer Information
... in Advanced Prostate Cancer (2/23/2005) Irofulven is Active against Metastatic Hormone-Refractory Prostate Cancer (2/14/2005) Men on Androgen Deprivation Therapy Not Receiving Adequate Screening or ...
- professional.cancerconsultants.com/oncology_prostate_cancer.aspx
Advance Hormone Refractory Prostate Cancer - Page 1
www.cpdr.org: US TOO Newsletter - ... Hormone Refractory Prostate Cancer - Celestia S. Higano, M.D. | Home | Newsletter | download article MAKING A DIFFERENCE IN ADVANCED HORMONE REFRACTORY ...
- www.cpdr.org/ustoo/aug2000/hormone/hormone1.shtml
Metastatic And Hormone Refractory Prostate cancer
... the implementation of screening in Europe LeadDiscovery Services Metastatic And Hormone Refractory Prostate cancer (HRPC) Introduction Prostate cancer is the most common male malignancy in Western ...
- www.leaddiscovery.co.uk/reports/Metastatic%20And%20Hormone%20Refractory%20Prostate%20cance...
- 3/18/2005
Clinical Cancer Research
... clinical and pharmacokinetic study of Kahalalide F in patients with advanced androgen refractory prostate cancer B7-H4 is highly expressed in ductal and lobular breast cancer Cancer Research Clinical ...
- clincancerres.aacrjournals.org
Prostate Cancer Information
... Cancer News FDA Agrees to File NDA for Xinlay™ in the Treatment of Metastatic Hormone-Refractory Prostate Cancer (2/25/2005) Abbott Laboratories announced on Friday, February 11, 2005 that the U.S ...
- patient.cancerconsultants.com/prostate_cancer_information.aspx
Prostate Cancer, Prostate Cancer Treatment, Prostate Cancer Support ...
... in prostate and other cancers Mayo Clinic Irofulven is Active against Metastatic Hormone-Refractory Prostate Cancer American Journal of ClinicalOncology More Prostate Cancer Treatment News Home | ...
Strategic _ Perspectives: _ Prostate _ Cancer _ - _ Issues _ in ...
... Prostate _ Cancer _ - _ Issues _ in _ Second-line, _ Brachytherapy _ and _ Hormone-Refractory _ Prostate _ Cancer _ Treatments Compaq _ Comp. _ MSA _ SAN _ SWITCH _ 2/8 _ ALL _ ( _ 288247-B21 _ ) Sharp ...
- cheap-shop.homeip.net/Strategic_Perspectives_B00008R40S.html
- 3/19/2005
Prostate Cancer Research Institute
... SB, Epstein A, Taylor C, Thompson L, and Mills, SL: Response of hormonally refractory prostate cancer (HRPC) to TNT-1 monoclonal antibody. Proc Am Soc Clin Oncol 13:239a, 1994. 5. Strum SB ...
- www.prostate-cancer.org/aboutus/acomplsh.html
- 3/19/2005
Prostate Cancer
... Prev 2001;10:861–8. 50. Matlaga BR, Hall MC, Stindt D, Torti FM. Response of hormone refractory prostate cancer to lycopene. J Urol 2001;166:613. 51. Chan JM, Giovannucci E, Andersson S-O, et al. Dairy ...
- www.publix.com/wellness/notes/Display.do?id=Concern&childId=Cancer_Prostate
- 3/19/2005